ADIS R&D Insight
Adis Insight from Wolters Kluwer Pharma Solutions comprises three products that together enable clients to effectively monitor competitor pipelines, evaluate products in development, assess commercial potential of upcoming products and evaluate trial evidence. R&D Insight is a drug pipeline database that tracks and evaluates drugs worldwide from discovery through to launch. Clinical Trials Insight is the only database to capture on-going trials from internet trial registries as well as trial results presented at medical conferences and published in scientific journals. Reactions Pharmacovigilance Insight allows fast and easy access to the adverse drug reaction case reports, drug safety studies and regulatory news impacting your market.
Bio Med Tracker
BioMedTracker identifies investment opportunities in the biotech and pharmaceutical industry by assessing the relative strength of companies’ clinical drug pipelines and by highlighting potential future catalysts that could dramatically impact those pipelines. The BioMedTracker team looks at clinical trial data and the regulatory history of each drug under coverage to assess its overall likelihood of approval by the FDA. Drugs are further analyzed for their commercial potential and presented in a 10-year Revenue Detail model for the U.S., Europe and Japan. Dates of approval, target patient populations, annual wholesale prices, market penetration, and other factors are estimated in formulating these revenue projections.
BioCentury IQ (BCIQ)
BCIQ, populated by the expert researchers at BioCentury, tracks corporate milestones, product development and fundraising events. These data are then placed into context with fully integrated links directly to BioCentury’s news and analysis in the complete BioCentury Archives, which is included in BCIQ. BCIQ also includes stock data and financial performance modules in addition to the company, pipeline and financing data sets. BCIQ provides custom management tools for users to personalize searches and reports. The database currently contains 5,800 public & private companies, $290 billion in financings and 8,000 biopharma products.
BioPharm Insight
BioPharm Insight includes the entire drug discovery and development pipeline, approved drugs, licensing deals, pharmaceutical sales/projections, management contacts, and more. It features detailed company profiles for over 4,100 Bio/Pharm companies, 36,000 investigational drugs including development history, clinical trials, mechanisms, patents, molecular structures, and licensing deals and 23,000+ approved drugs. The BioPharm Insight Licensing Agreement Database summarizes the most material information from company press releases and updates, financial statements, regulatory fillings, and news articles from the present day and dating back to 1984. The deal summary provides scope and background of the agreement, and financial & commercial terms of agreements. The database has seen over 11,000 drug licensing updates since inception including milestone & royalty payments, and terminations.
Citeline Trialtrove
TrialTrove covers interventional drug trials from Phase I to Phase IV giving a complete picture of competitors’ clinical programs by therapeutic area and disease, by analysing and investigating what’s going on behind the raw information. Trialtrove draws on 18,000+ information sources with information on 180 Disease areas and worldwide coverage of clinical trials activity. Features include email alerts as new information is added, data export for reporting and analysis and fully integration with Pipeline (drug database based on Pharmaprojects) and SiteTrove (investigator database).
Derwent Discovery
Derwent Drug File is the definitive and comprehensive source of drug-related literature and conference information, designed specifically to meet the needs of those working in biomedical research and the pharmaceutical industry. Derwent Drug File sources data from pharmaceutical literature worldwide, and now includes over 1.7 million references covering all aspects of drug development, synthesis, evaluation, manufacture and use. The unique combination of biological and chemical information enables you to easily relate the structure of compounds to their biological activity.
eKnowledgeBase
eKnowledgebase is an interactive online pharmaceutical database providing broad coverage on companies, as well as pipelines and products during each stage of development through approval and marketing. Updated daily, eKnowledgebase provides data on thousands of prescription drugs in development and brands on the market. Product and compound searches provide overview information, trial results, approval information, additional indication status, and product sales data. The newly redesigned eKnowledgebase will contain specific product-level data including prescriptions written, number of doctors prescribing, average price, refill data, prescribing trends and market share data.
Evaluate Pharma
Evaluate Pharma provides data and analytical tools so you can successfully identify in-licensing or out-licensing opportunities, potential product acquisitions arising from M&A activity or appraise growth prospects in underserved or emerging markets. Consensus product forecaststo 2016 for high level market analysis, includes royalty, joint venture and co-promotion incomes. Full financial company models to 2016 with Product, Therapy Area and Segment sales, plus full Financials – P&L, Balance Sheet, Cash Flow, and Valuation measures. Exclusive market analytics including Therapy Area, Pharma Class, EphMRA/ATC code, Technology, Product and Generic sales with standardized worldwide models. Historic sales data from 1986 onwards. Daily analysis on the market from EP Vantage which delivers forward-looking comment and analysis, putting market developments into commercial context. The online Interactive NPV (Net Present Value) Analyzer with over 3100 global product NPVs linked to share price enabling you to model the impact of future events on product, portfolio and company valuation is available for an additional subscription.
IMS Lifecycle
IMS LifeCycle brings together three of the most powerful IMS databases: R&D Focus monitors over 28,000 drugs in R&D with over 9,300 drugs in active development, of which over 5,900 are biotechnology products. New Product Focus details launches of over 290,000 new products launched worldwide since 1982 using data from IMS global product referencing systems. Patent Focus - evaluates 4,700 patent families with over 65,000 patent records with expiry and extension dates. Pipeline information is drawn from sources including company websites & press releases, R&D days, company investor conferences, internet news wires, scientific conferences, regulatory data (eg from FDA, EU EMEA), conference abstracts & posters and review journals.
Inteleos
Inteleos tracks global drug development from preclinical through approval and post-marketing studies. Uses for Inteleos include identifying unlicensed products for potential licensing opportunities, monitoring the progress of competitors' R&D programs and tracking drug development from preclinical through approval and post-marketing studies from more than 3,000 pharmaceutical and biotech companies. Users can customize alerts on content relevant to your portfolio or topics of interest and forecast success ratios per product, per indication and view development timelines.
MedTrack
MedTRACK is a database of private and public biomedical companies. MedTRACK contains pipeline, financial, competitive product, mechanism of action, sales, partnering, and patent information on 21,292 biomedical companies worldwide, encompassing 106,413 drugs, 55,326 deals, 13,559 venture transactions, 1,556 drug delivery technologies, 642 indications, 610,487 news classified, 141,823 management contacts, 117 countries, 479,535 SEC filings and more. The information can be sorted by parameters such as disease, competitive products, or clinical trial stage. Search functions reach into SEC filings, websites, business and product descriptions, journals, meeting abstracts, news, and announcements. MedTRACK makes it easy to find the data you need. Drill down on company fundamentals to establish an opinion, find partnering opportunities, or respond with educated agility to market news. Separate add-on subscriptions cover Deals & Alliances, Epidemiology data and Venture Capital investments.
Pharma Deals
Pharma Deals Agreements is a deals and alliances agreements database of over 30,000 deal records, which are continuously added to, updated and maintained by our specialist editorial team. The database covers all territories, including emerging markets, therapy areas and product stages of development, and allows immediate access to financials, to full-text contracts from US SEC filings, and to associated press materials. An advanced search facility enables you to find and store the deals you need: You can search by therapeutic area, deal type (e.g. co-development, out-licensing); financial information, development phase (preclinical, Phase I,II, etc.), technology/product type (e.g. antibody, small molecule, assay, etc.), or any keyword. All deals are now classified according to: specific indications; territories can be searched by continent, region or individual country, giving you greater control over your searches; users can differentiate between therapeutic, diagnostic and technology deals to enable rapid and reliable analysis of the database. Subscription also includes PharmaDeals Review, which offers expert analysis as deals occur, and includes an archive of in-depth review articles, a deal tracker, analyst opinion, and business commentaries on topical business and industry issues, and how they affect deal making.
Pharmacircle
Pharma Circle's comprehensive product & pipeline information (research phase to marketed) from 4976 companies around the globe is searchable for every imaginable details (phase, indication, route, partnerships, molecule type, mechanism, delivery route, dose, administration, exclusivity, pharmacokinetic and physical chemical properties of molecules).
Pharmaprojects
Pharmaprojects contains over 46,000 drug profiles from 1,600 companies collected over 26 years, with highly detailed information. It is available as a stand-alone solution, or can be accessed via TrialTrove, another Informa product. Each record contains over 75 different criteria and the database features 968 individual, searchable diseases, chemical structure search facility and random, combination and Boolean searches. Pharmaprojects can help business development professionals to identify in-licensing and investment opportunities, monitor competitors’ development programmes and predict the future competitive landscape for drugs in development.
Pharmavitae
PharmaVitae Explorer brings together sales, pipeline and financial data on the top 50 pharmaceutical and biotechnology companies from Datamonitor's PharmaVitae reports in a single easy-to-use online interface. The portfolio of data is based on years of primary and secondary research, allied with our analysts’ own unique knowledge of the pharmaceutical industry. PharmaVitae Explorer provides monthly updated database of 1,500+ independent drug sales forecasts where products are searchable by 15 key market dimensions including company, therapy area, ATC code and lifecycle stage. Detailed historical and forecast company financials including operating cost and profit data are included.
Recap
DEAL builder is a database of 30,000 deal announcements, updated daily, with the underlying press releases and 24,000 SEC-filed contracts, 12,000 patents, 5,000 clinical trials, 14,000 biocontacts, and round-by-round financing for over 700 companies. VALUATION analyzer provides access to Recap's effective royalty rate (EFR) Grapher to perform real-time searches of over 1,500 Biopharma alliances and graphs the trends in EFR for deals by stage of development at signing.
Strategic Transactions
Strategic Transactions is a fully searchable database of pharmaceutical, biotechnology, diagnostic and device deals plus tech Transfers. It includes comprehensive deal records, financial information, extensive company profiles and access to SEC documents. It also integrates with relevant publications from Elsevier Business Intelligence: IN VIVO, Start-UP, The RPM Report and Medtech Insight. Strategic Transactions helps to answer questions such as "What's the value of deals in my specific therapeutic area?", "How do smaller firms successfully structure deals to win against bigger, richer players?" or "Which companies would pay the highest price for my niche product?".
Thomson Reuters Integrity
Integrity is a drug discovery and development portal, encompasing all knowledge areas in drug discovery and development, including chemistry, genomics, tissue engineering, pharmacodynamics, pharmacokinetics and pathology. Integrity enables researchers to manage and correlate chemistry and genomics data with pharmacodynamics and pharmacokinetics data and with a knowledge base of disease entities. Now known as Thomson Reuters Integrity, formerly Prous Integrity.
Thomson Reuters Partnering
Thomson Reuters Partnering offers a comprehensive look at drugs currently in development, the companies developing them, and their market potential. For each potential partner and drug profiled, you can learn financial details, research interests, areas of therapeutic and technology expertise as well as existing licensing agreements, and much more. Thomson Reuters Partnering is powered by IDdb, recognized as the world leader in drug pipeline information.
Thomson Reuters Pharma
Thomson Reuters Pharma brings together multiple pharmaceutical data sources owned by Thomson Reuters in a single system. It covers a broad range of competitor intelligence topics — the latest drugs, compounds, genetic sequences and targets, clinical trials and licensing opportunities, patents, journals, conferences, academic articles and more. Unique abstracts, commentaries and analysis, prepared by a team of industry experts, put this information in context and explain its significance. Thomson Pharma offers access to 33,000 drug monographs, 7500 company profiles, 60 000 clinical trial protocols, 13,000 drug targets and 20,000 deals.
Venture Deal
VentureDeal is a database that provides the latest information about venture capital, venture-backed technology companies, venture capital firms and transactions in the United States. VentureDeal is updated daily and offers convenient access to detailed and actionable information for business development, venture capital financing search and investment goals.
VentureSource
VentureSource tracks the key developments of more the 30,000 venture-backed companies in every industry and every region in the U.S., Europe, Israel and China. It also tracks the moves and people of over 8,000 private capital firms around the world. It gives professionals access to accurate investment benchmarks, competitive intelligence, potential co-investors, in-depth fundraising details, liquidity data and much more. Seasoned researchers-including teams on the ground in Europe and Asia work tirelessly to update the database with fresh data on companies and investors in all parts of the world, including: Europe, U.S, Canada, Greater China, Israel, India and the Middle East.
VentureXpert
VentureXpert is now available as the Private Equity module of Thomson ONE Investment Banking, a high end platform including all sorts of financial information. It includes over 30 years of data covering buyouts, private equity funds, firms, executives, portfolio companies and limited partners around the world. Over 1.2 million global private companies are covered including detailed profiles of portfolio companies, firms and funds with precise industry classifications.
Information is taken mainly from vendor's own marketing material. Please get in touch with suggestions for updated content, including any resources we may have missed.
